Unicharm Corp. engages in the manufacture and sale of baby, feminine, pet, and health care products. It operates through the following segments: Personal Care, Pet Care and Others. The Personal Care segment handles baby care, feminine care, health care, and clean-and-fresh products, which include the brands moony, Natural moony, MamyPoko, Center-in, Kiyora, Sofy, Lifree, Charm Nap, and Silcot. The Pet Care segment deals with the production of pet food and pet toiletries, which include the brands Aiken Genki, Neko Genki, Gin no Spoon, Deo-Sheet, Deo-Manner-Wear, Deo-Sand, and Deo-Toilet. The Others segment manages commercial products that used in nonwoven fabric. It also offers industrial and food packaging materials. The company was founded by Keiichiro Takahara on February 10, 1961 and is headquartered in Tokyo, Japan.

Manufactures pharmaceuticals

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. The Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neurological and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study.

Ferring BV offers pharmaceutical products. It offers medicines in Gynaecology, Gastroenterology, Endocrinology and Urology. The company was founded in 1984 and is headquartered in Hoofddorp, Netherlands.

Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.

Cellectis AB, a subsidiary of Takara Holdings, Inc., is a Swedish company located in Gothenburg. The firm manufactures and distributes stem cell-related products. On September 04, 2014 Takara Bio, Inc. acquired Cellectis AB from Cellectis SA.

Carematix, Inc. is a private company headquartered in the United States that deigns and manufactures hardware, software engineering product and system for healthcare industry.

Shanghai Yurui Information Technology Co., Ltd., established on 2016-06-27, Business scope includes licensed projects:career brokerage;Mapping service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,General machinery and equipment installation services,General Equipment Repair,Information Consulting Service(Not including licensing information consulting services),Conference and Exhibition Services,Information system integration service,Camera and Video Production Services,Geographic Remote Sensing Information Service,Security System Monitoring Services,Security equipment sales,Machinery and Equipment Leasing,Sales of civil aviation materials,Camera and Equipment Sales,Instrument sales,Machinery sales,Sales of electrical machinery and equipment,electronics sales,Civilian Unmanned Aircraft Operations(see license).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nissin Foods Holdings Co., Ltd. engages in the management of its group companies which are in the food manufacturing business. It operates through the following segments: Nissin Food Products, Myojo Foods, Chilled and Frozen Foods, The Americas, China, and Others. The Nissin Food Products, Myojo Foods, The Americas, and China segments produces and sells cup and bag-type instant noodles and processed food products. The Chilled and Frozen Foods segment offers chilled and frozen food products. The Others segment includes confectioneries, beverages, food services, and businesses in Europe and Asia region. The company was founded by Momofuku Ando on September 4, 1948 and is headquartered in Tokyo, Japan.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

The Lee Co. supplies precision fluid control products to industries including aerospace, formula 1 racing, oil exploration, automotive and off-highway equipment, and medical and scientific instruments. Its products include precision microhydraulics and electro-fluidic systems. The company was founded by Leighton Lee II in 1948 and is headquartered in Westbrook, CT.

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (“Zealand”) is a biotech company with leading-edge scientific expertise in turning peptides into medicines. Zealand has a growing proprietary pipeline of novel specialty drug candidates and a mature portfolio of products and projects under license collaborations with Sanofi, Helsinn Healthcare and Boehringer Ingelheim. Zealand’s first invented medicine, lixisenatide, a once-daily prandial GLP-1 analogue for the treatment of Type 2 diabetes, is marketed globally outside the US as Lyxumia:registered: by Sanofi and under regulatory review in the US. The license collaboration with Sanofi covers also a single-product combination of lixisenatide and insulin glargine (Lantus:registered:) which is on track for regulatory submission in the US in December 2015 and in the European Union in Q1 2016. The proprietary pipeline includes; danegaptide for ischemic reperfusion Injuries in Phase II development; ZP1848 for Short Bowel Syndrome in Phase II development; and the stable glucagon analogue, ZP4207, in Phase II preparation both as a single-dose rescue pen for severe hypoglycemia and for multiple-dose use to treat and control mild to moderate hypoglycemia; as well as several preclinical peptide therapeutics. The company is based in Copenhagen (Glostrup), Denmark. For further information about Zealand’s business and activities, please visit: www.zealandpharma.com or follow us on Twitter @ZealandPharma

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.